Cargando…

The Prevalence of Multidrug Resistance of Helicobacter pylori and Its Impact on Eradication in Korea from 2017 to 2019: A Single-Center Study

Antimicrobial resistance is one of the major factors determining the efficacy of Helicobacter pylori eradication therapy. This study aimed to estimate the recent prevalence of multidrug resistance of H. pylori and its impact on eradication in Korea. A total of 174 patients were prospectively enrolle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jae Yong, Shin, Tae-Seop, Kim, Ji Hyun, Yoon, Hong Jip, Kim, Beom Jin, Kim, Jae Gyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601770/ https://www.ncbi.nlm.nih.gov/pubmed/32992624 http://dx.doi.org/10.3390/antibiotics9100646

Ejemplares similares

Clarithromycin-Based Standard Triple Therapy Can Still Be Effective for Helicobacter pylori Eradication in Some Parts of the Korea
por: Yoon, Kyu-Hyun, et al.
Publicado: (2014)

Discovery of a Novel Mutation in DNA Gyrase and Changes in the Fluoroquinolone Resistance of Helicobacter pylori over a 14-Year Period: A Single Center Study in Korea
por: Rhie, Su Yeon, et al.
Publicado: (2020)

Developing Operational Definitions Related to Helicobacter pylori Eradication Therapy
por: Park, Chan Hyuk, et al.
Publicado: (2023)

Online registry for nationwide database of Helicobacter pylori eradication in Korea: Correlation of antibiotic use density with eradication success
por: Kim, Beom Jin, et al.
Publicado: (2019)

Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis
por: Kim, Beom Jin, et al.
Publicado: (2016)

Antibiotic Resistance in Helicobacter pylori Strains and its Effect on H. pylori Eradication Rates in a Single Center in Korea
por: An, Byoungrak, et al.
Publicado: (2013)

The Effects of Helicobacter pylori Eradication Therapy for Chronic Idiopathic Thrombocytopenic Purpura
por: Hwang, Jae Jin, et al.
Publicado: (2016)

The Influence of Past Metronidazole Exposure on the Outcome of Helicobacter pylori Eradication
por: Choe, Younghee, et al.
Publicado: (2022)

Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients
por: Choi, Youn I, et al.
Publicado: (2021)

Long-term Effects of the Eradication of Helicobacter pylori on Metabolic Parameters, Depending on Sex, in South Korea
por: Park, Jaehyung, et al.
Publicado: (2023)

Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease
por: Lim, Joo Hyun, et al.
Publicado: (2017)

Effect of Helicobacter pylori Eradication on Functional Dyspepsia
por: Kim, Sung Eun, et al.
Publicado: (2013)

The analysis of virulence factors and antibiotic resistance between Helicobacter pylori strains isolated from gastric antrum and body
por: Seo, Ji Won, et al.
Publicado: (2019)

Two Cases of Russell Body Gastritis Treated by Helicobacter pylori Eradication
por: Yoon, Jung Bin, et al.
Publicado: (2012)

Treatment of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis
por: Lee, Sang Wook, et al.
Publicado: (2015)

Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy
por: Kim, Sung Eun, et al.
Publicado: (2015)

Outcome of Immunosuppressive Therapy with Helicobacter pylori Eradication Therapy in Patients with Chronic Idiopathic Thrombocytopenic Purpura
por: Song, Moo-Kon, et al.
Publicado: (2008)

Current Status of the Third-Line Helicobacter pylori Eradication
por: Choi, Jae Ho, et al.
Publicado: (2018)

Role of potassium-competitive acid blockers in eradication of Helicobacter pylori infection
por: Kim, Tae Ho
Publicado: (2023)

Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea 2020
por: Jung, Hye-Kyung, et al.
Publicado: (2021)

Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020
por: Jung, Hye-Kyung, et al.
Publicado: (2021)

Helicobacter pylori: Eradication or Preservation
por: Sachs, George, et al.
Publicado: (2012)

Helicobacter pylori Eradication, a Gordian Knot for Idiopathic Thrombocytopenic Purpura?
por: Kim, Tae Ho, et al.
Publicado: (2016)

Effects of Helicobacter pylori eradication in patients with immune thrombocytopenic purpura
por: Tag, Hee Sang, et al.
Publicado: (2010)

Helicobacter pylori-derived outer membrane vesicles stimulate interleukin 8 secretion through nuclear factor kappa B activation
por: Choi, Mun Sun, et al.
Publicado: (2021)

Fermented‐Rhus verniciflua extract ameliorate Helicobacter pylori eradication rate and gastritis
por: Kim, Seungwoo, et al.
Publicado: (2020)

Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer
por: Bang, Chang Seok, et al.
Publicado: (2015)

Comparison of the Eradication Rate between 1- and 2-Week Bismuth-Containing Quadruple Rescue Therapies for Helicobacter pylori Eradication
por: Yoon, Jai Hoon, et al.
Publicado: (2012)

Meta-Analysis of First-Line Triple Therapy for Helicobacter pylori Eradication in Korea: Is It Time to Change?
por: Gong, Eun Jeong, et al.
Publicado: (2014)

Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development
por: Han, Seung Jun, et al.
Publicado: (2018)

Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial
por: Choi, Youn I, et al.
Publicado: (2019)

Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects
por: Park, Hyeonsoo, et al.
Publicado: (2020)

Helicobacter pylori Eradication Reduces the Metachronous Recurrence of Gastric Neoplasms by Attenuating the Precancerous Process
por: Jung, Da Hyun, et al.
Publicado: (2015)

Helicobacter pylori Eradication Downregulates Cellular Inhibitor of Apoptosis Protein 2 in Gastric Carcinogenesis
por: Yoon, Hyuk, et al.
Publicado: (2017)

Additive Effect of Pronase on the Eradication Rate of First-Line Therapy for Helicobacter pylori Infection
por: Bang, Chang Seok, et al.
Publicado: (2015)

Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
por: Kim, Sung Eun, et al.
Publicado: (2017)

Newer agents for Helicobacter pylori eradication
por: Fiorini, Giulia, et al.
Publicado: (2012)

Recent advances in Helicobacter pylori eradication
por: Niv, Yaron, et al.
Publicado: (2015)

Helicobacter pylori eradication in the management of glaucoma
por: Ala, Shahram, et al.
Publicado: (2020)

Efficacy of Vonoprazan for Helicobacter pylori Eradication
por: Kiyotoki, Shu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_utdrgvik1r1mm5qlg6ibg15pvh